BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25776504)

  • 1. MTDH/AEG-1-based DNA vaccine suppresses metastasis and enhances chemosensitivity to paclitaxel in pelvic lymph node metastasis.
    Zhang C; Li HZ; Qian BJ; Liu CM; Guo F; Lin MC
    Biomed Pharmacother; 2015 Mar; 70():217-26. PubMed ID: 25776504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MTDH/AEG-1-based DNA vaccine suppresses lung metastasis and enhances chemosensitivity to doxorubicin in breast cancer.
    Qian BJ; Yan F; Li N; Liu QL; Lin YH; Liu CM; Luo YP; Guo F; Li HZ
    Cancer Immunol Immunother; 2011 Jun; 60(6):883-93. PubMed ID: 21400023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTDH/AEG-1 contributes to central features of the neoplastic phenotype in bladder cancer.
    Nikpour M; Emadi-Baygi M; Fischer U; Niegisch G; Schulz WA; Nikpour P
    Urol Oncol; 2014 Jul; 32(5):670-7. PubMed ID: 24495449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3β signaling pathway.
    Chang Y; Jia HQ; Xu B; Yang L; Xu YT; Zhang JY; Wang MQ; Yang LX; Song ZC
    Chem Biol Drug Des; 2024 Jan; 103(1):e14416. PubMed ID: 38093418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel DNA/peptide combined vaccine induces PSCA-specific cytotoxic T-lymphocyte responses and suppresses tumor growth in experimental prostate cancer.
    Zhang KQ; Yang F; Ye J; Jiang M; Liu Y; Jin FS; Wu YZ
    Urology; 2012 Jun; 79(6):1410.e7-13. PubMed ID: 22513035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis.
    Emdad L; Das SK; Dasgupta S; Hu B; Sarkar D; Fisher PB
    Adv Cancer Res; 2013; 120():75-111. PubMed ID: 23889988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer.
    He Q; Li J; Yin W; Song Z; Zhang Z; Yi T; Tang J; Wu D; Lu Y; Wang Z; Liu D; Zhang X; Hu Z; Gao J
    Cancer Immunol Immunother; 2011 May; 60(5):715-30. PubMed ID: 21331814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro.
    Yang L; Tian Y; Leong WS; Song H; Yang W; Wang M; Wang X; Kong J; Shan B; Song Z
    Breast Cancer Res; 2018 Sep; 20(1):113. PubMed ID: 30227879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Cancer Res; 2000 May; 60(9):2547-54. PubMed ID: 10811138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AEG-1/MTDH/LYRIC in liver cancer.
    Sarkar D
    Adv Cancer Res; 2013; 120():193-221. PubMed ID: 23889992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multifaceted role of MTDH/AEG-1 in cancer progression.
    Hu G; Wei Y; Kang Y
    Clin Cancer Res; 2009 Sep; 15(18):5615-20. PubMed ID: 19723648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance mediated by AEG-1/MTDH/LYRIC.
    Meng X; Thiel KW; Leslie KK
    Adv Cancer Res; 2013; 120():135-57. PubMed ID: 23889990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AEG-1/MTDH/LYRIC: clinical significance.
    Sarkar D; Fisher PB
    Adv Cancer Res; 2013; 120():39-74. PubMed ID: 23889987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting.
    Lu H; Li B; Kang Y; Jiang W; Huang Q; Chen Q; Li L; Xu C
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):175-81. PubMed ID: 16718469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease.
    Noch EK; Khalili K
    Adv Cancer Res; 2013; 120():159-92. PubMed ID: 23889991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic roles of AEG-1/MTDH/LYRIC in breast cancer.
    Wan L; Kang Y
    Adv Cancer Res; 2013; 120():113-34. PubMed ID: 23889989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
    Latimer P; Menchaca M; Snyder RM; Yu W; Gilbert BE; Sanders BG; Kline K
    Exp Biol Med (Maywood); 2009 Oct; 234(10):1244-52. PubMed ID: 19657067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.